Exploring the Active Ingredients and Mechanism of Action of Huanglian Huazhuo Capsule for the Treatment of Obese Type-2 Diabetes Mellitus Based on Using Network Pharmacology and Molecular Docking

Figure 9

Docking patterns of key targets and specific active compounds. Tanshinone IIA-STAT3 (a), tanshinone IIA-MAPK1 (b), luteolin-RELA (c), tanshinone IIA-IL6 (d), stigmasterol-TNF (e), quercetin-ESR1 (f), and tanshinone IIA-IL10 (g).

(a)

(b)

(c)

(d)

(e)

(f)

(g)